# GoPro, Inc.: financial statements, quarterly

GPRO · Nasdaq · CIK 1500435 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gpro.md) · [Financials](/companies/gpro/financials.md) · [Filings](/companies/gpro/filings.md) · [Insiders](/companies/gpro/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gpro/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [294](/filings/0001500435-24-000154.md) | [295 d](/filings/0001500435-26-000068.md) | [155](/filings/0001500435-25-000034.md) | [186](/filings/0001500435-25-000058.md) | [259](/filings/0001500435-25-000095.md) | [201 d](/filings/0001500435-26-000068.md) | [134](/filings/0001500435-26-000069.md) | [153](/filings/0001500435-26-000070.md) | [163](/filings/0001500435-25-000095.md) | [202 d](/filings/0001500435-26-000068.md) | [99.1](/filings/0001500435-26-000069.md) | [105](/filings/0001500435-26-000070.md) |
| Cost of revenue | $m | [200](/filings/0001500435-24-000154.md) | [194 d](/filings/0001500435-26-000068.md) | [102](/filings/0001500435-25-000034.md) | [130](/filings/0001500435-25-000058.md) | [167](/filings/0001500435-25-000095.md) | [131 d](/filings/0001500435-26-000068.md) | [91.2](/filings/0001500435-26-000069.md) | [98.0](/filings/0001500435-26-000070.md) | [106](/filings/0001500435-25-000095.md) | [137 d](/filings/0001500435-26-000068.md) | [94.8](/filings/0001500435-26-000069.md) | [73.3](/filings/0001500435-26-000070.md) |
| Gross profit | $m | [94.2](/filings/0001500435-24-000154.md) | [101 d](/filings/0001500435-26-000068.md) | [53.0](/filings/0001500435-25-000034.md) | [56.7](/filings/0001500435-25-000058.md) | [91.8](/filings/0001500435-25-000095.md) | [69.7 d](/filings/0001500435-26-000068.md) | [43.1](/filings/0001500435-26-000069.md) | [54.7](/filings/0001500435-26-000070.md) | [57.2](/filings/0001500435-25-000095.md) | [64.2 d](/filings/0001500435-26-000068.md) | [4.3](/filings/0001500435-26-000069.md) | [31.7](/filings/0001500435-26-000070.md) |
| Research and development | $m | [41.7](/filings/0001500435-24-000154.md) | [43.9 d](/filings/0001500435-26-000068.md) | [44.6](/filings/0001500435-25-000034.md) | [46.9](/filings/0001500435-25-000058.md) | [44.3](/filings/0001500435-25-000095.md) | [50.0 d](/filings/0001500435-26-000068.md) | [29.6](/filings/0001500435-26-000069.md) | [30.5](/filings/0001500435-26-000070.md) | [34.6](/filings/0001500435-25-000095.md) | [32.1 d](/filings/0001500435-26-000068.md) | [28.4](/filings/0001500435-26-000069.md) | [29.6](/filings/0001500435-26-000070.md) |
| Operating income | $m | [(3.8)](/filings/0001500435-24-000154.md) | [(9.4) d](/filings/0001500435-26-000068.md) | [(41.4)](/filings/0001500435-25-000034.md) | [(46.5)](/filings/0001500435-25-000058.md) | [(8.0)](/filings/0001500435-25-000095.md) | [(39.1) d](/filings/0001500435-26-000068.md) | [(45.2)](/filings/0001500435-26-000069.md) | [(14.0)](/filings/0001500435-26-000070.md) | [(15.9)](/filings/0001500435-25-000095.md) | [(8.2) d](/filings/0001500435-26-000068.md) | [(57.2)](/filings/0001500435-26-000069.md) | [(39.0)](/filings/0001500435-26-000070.md) |
| Interest expense | $m | [1.2](/filings/0001500435-24-000154.md) | [1.2 d](/filings/0001628280-25-013046.md) | [0.7](/filings/0001500435-25-000034.md) | [0.8](/filings/0001500435-25-000058.md) | [0.8](/filings/0001500435-24-000154.md) | [1.1 d](/filings/0001628280-25-013046.md) | [0.8](/filings/0001500435-25-000034.md) | [1.4](/filings/0001500435-25-000058.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.7](/filings/0001500435-24-000154.md) | [(3.0) d](/filings/0001500435-26-000068.md) | [298](/filings/0001500435-25-000034.md) | [1.3](/filings/0001500435-25-000058.md) | [2.1](/filings/0001500435-25-000095.md) | [(2.4) d](/filings/0001500435-26-000068.md) | [1.7](/filings/0001500435-26-000069.md) | [1.3](/filings/0001500435-26-000070.md) | [0.8](/filings/0001500435-25-000095.md) | [(1.7) d](/filings/0001500435-26-000068.md) | [1.8](/filings/0001500435-26-000069.md) | [0.8](/filings/0001500435-26-000070.md) |
| Net income | $m | [(3.7)](/filings/0001500435-24-000154.md) | [(2.4) d](/filings/0001500435-26-000068.md) | [(339)](/filings/0001500435-25-000095.md) | [(47.8)](/filings/0001500435-25-000095.md) | [(8.2)](/filings/0001500435-25-000095.md) | [(37.2) d](/filings/0001500435-26-000068.md) | [(46.7)](/filings/0001500435-26-000070.md) | [(16.4)](/filings/0001500435-26-000070.md) | [(27.4)](/filings/0001500435-26-000068.md) | [(2.1)](/filings/0001500435-26-000068.md) | [(76.3)](/filings/0001500435-26-000070.md) | [(51.2)](/filings/0001500435-26-000070.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001500435-24-000154.md) | not reported | [(2.24)](/filings/0001500435-25-000034.md) | [(0.31)](/filings/0001500435-25-000058.md) | [(0.05)](/filings/0001500435-25-000095.md) | not reported | [(0.30)](/filings/0001500435-26-000069.md) | [(0.10)](/filings/0001500435-26-000070.md) | [(0.17)](/filings/0001500435-26-000068.md) | [(0.01)](/filings/0001500435-26-000068.md) | [(0.47)](/filings/0001500435-26-000069.md) | [(0.30)](/filings/0001500435-26-000070.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0001500435-24-000154.md) | not reported | [(2.24)](/filings/0001500435-25-000034.md) | [(0.31)](/filings/0001500435-25-000058.md) | [(0.05)](/filings/0001500435-25-000095.md) | not reported | [(0.30)](/filings/0001500435-25-000034.md) | [(0.10)](/filings/0001500435-25-000058.md) | [(0.13)](/filings/0001500435-25-000095.md) | not reported | [(0.47)](/filings/0001500435-26-000069.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [221](/filings/0001500435-24-000154.md) | [223](/filings/0001500435-26-000068.md) | [134](/filings/0001500435-25-000034.md) | [133](/filings/0001500435-25-000058.md) | [130](/filings/0001500435-25-000095.md) | [103](/filings/0001500435-26-000068.md) | [69.6](/filings/0001500435-26-000069.md) | [58.6](/filings/0001500435-26-000070.md) | [153](/filings/0001500435-25-000095.md) | [49.7](/filings/0001500435-26-000070.md) | [40.7](/filings/0001500435-26-000069.md) | [27.3](/filings/0001500435-26-000070.md) |
| Current assets | $m | [560](/filings/0001500435-23-000080.md) | [483](/filings/0001628280-25-013046.md) | [370](/filings/0001500435-24-000080.md) | [351](/filings/0001500435-24-000132.md) | [455](/filings/0001500435-24-000154.md) | [339](/filings/0001500435-26-000068.md) | [279](/filings/0001500435-25-000034.md) | [255](/filings/0001500435-25-000058.md) | [359](/filings/0001500435-25-000095.md) | [253](/filings/0001500435-26-000070.md) | [207](/filings/0001500435-26-000069.md) | [229](/filings/0001500435-26-000070.md) |
| Total assets | $m | [1,046](/filings/0001500435-23-000080.md) | [968](/filings/0001628280-25-013046.md) | [576](/filings/0001500435-24-000080.md) | [557](/filings/0001500435-24-000132.md) | [662](/filings/0001500435-24-000154.md) | [544](/filings/0001500435-26-000068.md) | [463](/filings/0001500435-25-000034.md) | [439](/filings/0001500435-25-000058.md) | [539](/filings/0001500435-25-000095.md) | [428](/filings/0001500435-26-000070.md) | [381](/filings/0001500435-26-000069.md) | [398](/filings/0001500435-26-000070.md) |
| Current liabilities | $m | [301](/filings/0001500435-23-000080.md) | [279](/filings/0001628280-25-013046.md) | [220](/filings/0001500435-24-000080.md) | [238](/filings/0001500435-24-000132.md) | [344](/filings/0001500435-24-000154.md) | [356](/filings/0001500435-26-000068.md) | [317](/filings/0001500435-25-000034.md) | [309](/filings/0001500435-25-000058.md) | [379](/filings/0001500435-25-000095.md) | [277](/filings/0001500435-26-000070.md) | [349](/filings/0001500435-26-000069.md) | [398](/filings/0001500435-26-000070.md) |
| Total liabilities | $m | [487](/filings/0001500435-23-000080.md) | [412](/filings/0001628280-25-013046.md) | [351](/filings/0001500435-24-000080.md) | [372](/filings/0001500435-24-000132.md) | [478](/filings/0001500435-24-000154.md) | [392](/filings/0001500435-26-000068.md) | [353](/filings/0001500435-25-000034.md) | [341](/filings/0001500435-25-000058.md) | [464](/filings/0001500435-26-000068.md) | [351](/filings/0001500435-26-000070.md) | [378](/filings/0001500435-26-000069.md) | [428](/filings/0001500435-26-000070.md) |
| Long-term debt | $m | [142](/filings/0001500435-23-000080.md) | [92.6](/filings/0001628280-25-013046.md) | [92.7](/filings/0001500435-24-000080.md) | [92.9](/filings/0001500435-24-000132.md) | [93.1](/filings/0001500435-24-000154.md) | [0.0](/filings/0001500435-26-000068.md) | not reported | not reported | [36.3](/filings/0001500435-26-000068.md) | [36.6](/filings/0001500435-26-000070.md) | [0.0](/filings/0001500435-26-000069.md) | [0.0](/filings/0001500435-26-000070.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [93.2](/filings/0001500435-26-000068.md) | [118](/filings/0001500435-25-000034.md) | [98.5](/filings/0001500435-25-000058.md) | [138](/filings/0001500435-25-000095.md) | [19.6](/filings/0001500435-26-000070.md) | [94.3](/filings/0001500435-26-000069.md) | [81.7](/filings/0001500435-26-000070.md) |
| Shareholders' equity | $m | [559](/filings/0001500435-24-000154.md) | [556](/filings/0001500435-26-000068.md) | [225](/filings/0001500435-25-000095.md) | [185](/filings/0001500435-25-000095.md) | [184](/filings/0001500435-25-000095.md) | [152](/filings/0001500435-26-000070.md) | [110](/filings/0001500435-26-000070.md) | [97.9](/filings/0001500435-26-000070.md) | [74.3](/filings/0001500435-26-000068.md) | [77.4](/filings/0001500435-26-000070.md) | [3.5](/filings/0001500435-26-000070.md) | [(29.3)](/filings/0001500435-26-000070.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.6) d](/filings/0001500435-24-000154.md) | [43.7 d](/filings/0001500435-26-000068.md) | [(98.4)](/filings/0001500435-25-000034.md) | [0.6 d](/filings/0001500435-25-000058.md) | [(2.2) d](/filings/0001500435-25-000095.md) | [(25.1) d](/filings/0001500435-26-000068.md) | [(57.2)](/filings/0001500435-26-000069.md) | [8.8 d](/filings/0001500435-26-000070.md) | [12.2](/filings/0001500435-26-000068.md) | [15.6](/filings/0001500435-26-000068.md) | [(36.6)](/filings/0001500435-26-000069.md) | [(10.8) d](/filings/0001500435-26-000070.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001500435-24-000154.md) | [0.5 d](/filings/0001500435-26-000068.md) | [1.0](/filings/0001500435-25-000034.md) | [0.7 d](/filings/0001500435-25-000058.md) | [1.9 d](/filings/0001500435-25-000095.md) | [0.4 d](/filings/0001500435-26-000068.md) | [1.3](/filings/0001500435-26-000069.md) | [0.5 d](/filings/0001500435-26-000070.md) | [0.9 d](/filings/0001500435-25-000095.md) | [0.6 d](/filings/0001500435-26-000068.md) | [1.0](/filings/0001500435-26-000069.md) | [1.0 d](/filings/0001500435-26-000070.md) |
| Share repurchases | $m | [10.0 d](/filings/0001500435-24-000154.md) | [10.0 d](/filings/0001500435-26-000068.md) | [0.0](/filings/0001500435-24-000080.md) | [0.0 d](/filings/0001500435-24-000132.md) | [0.0 d](/filings/0001500435-24-000154.md) | [0.0 d](/filings/0001500435-26-000068.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [155](/filings/0001500435-23-000049.md) | [155](/filings/0001500435-24-000132.md) | [152](/filings/0001500435-24-000154.md) | [151](/filings/0001500435-25-000034.md) | [153](/filings/0001500435-25-000058.md) | [154](/filings/0001500435-25-000095.md) | [156](/filings/0001500435-26-000069.md) | [158](/filings/0001500435-26-000070.md) | [159](/filings/0001500435-26-000068.md) | [161](/filings/0001500435-26-000068.md) | [163](/filings/0001500435-26-000069.md) | [171](/filings/0001500435-26-000070.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.